Auditor: Del. Prescription Program Overspent By $24.5-M


Delaware has been overpaying its pharmacy benefits manager for state employees’ prescription drug coverage over a three-year period. The overpayment amounts to $24.5-million taxpayer dollars, according to…

Read More

Del. Steps Up Spending Of CARES Act Funds


Delaware spent $5-million more in federal CARES Act funding last week compared to the previous week, according to the CARES Act Fund Tracker developed by State Auditor…

Read More